Peptide deformylase: A target for novel antibiotics?

Expert Opinion on Therapeutic Targets

Volumn 5, Issue 1, 2001, Pages 23-40

  Pei, Dehua ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

antibacterial drugs; antibiotic; deformylase inhibitor; deformylation; formylation; iron protein; metalloenzyme; metallopeptidase; peptide deformylase; prodrug

Indexed keywords

EID: 0001979104     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.5.1.23     Document Type: Review

References (109)

1. NEU HC: The crisis in antibiotic resistance. Science (1992) 257:1064-1073.
2. KOZAK M: Comparison of initiation of protein synthesis in prokaryotes, eukaryotes and organelles. Microbiol. Rev. (1983) 47:1-45.
3. MEINNEL T, MECHULAM Y, BLANQUET S: Methionine as translation start signal: Areview of the enzymes of the pathway in Escherichia coli. Biochimie (1993) 75:1061-1075.
4. ADAMS JM, CAPECCHI M: The role of N-formylmethionine-sRNA as the initiator of protein synthesis. Proc. Natl. Acad. Sci. USA (1966) 55:147-155.
5. WEBSTER RE, ENGELHARDT DL, ZINDER ND: In vitro protein synthesis: chain initiation. Proc. Natl. Acad. Sci. USA (1966) 55:155-161.
6. MARCKER K, SANGER F: N-Formyl-methionyl-sRNA. J. Mol. Biol. (1964) 8:835-840.
7. ADAMS JM: On the release of the formyl group from nascent protein. J. Mol. Biol. (1968) 33:571-589.
8. LIVINGSTON DM, LEDER P: Deformylation and protein synthesis. Biochemistry (1969) 8:435-443.
9. TAKEDA M, WEBSTER RE: Protein chain initiation and deformylation in B. subtilis homogenates. Proc. Natl. Acad. Sci. USA (1968) 60:1487-1494.
10. BEN-BASSAT A, BAUER K, CHANG SY, MYAMBO K, BOOSMAN A, CHANG, S: Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure. J. Bacteriol. (1987) 169:751-757.
11. MILLER CG, STRAUCH KL, KUKRAL AM et al: N-Terminal methionine specific peptidase in Salmonella typhimurium. Proc. Natl. Acad. Sci. USA (1987) 84:2718-2722.
12. HIREL PH, SCHMITTER JM, DESSEN P, FAYAT G, BLANQUET S: Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc. Natl. Acad. Sci. USA (1989) 86:8247-8251.
13. WALLER JP: The NH2-terminal residue of the proteins from cell-free extract of E. coli. J. Mol. Biol. (1963) 7:483-496.
14. VARSHNEY U, RAJBHANDARY UL: Role of methionine and formylation of initiator tRNA in initiation of protein synthesis in Escherichia coli. J. Bacteriol. (1992) 174:7819-7826.
15. GUILLON JM, MECHULAM Y, BLANQUET S, FAYAT G: Importance of formylability and anticodon stem sequence to give tRNAMet an initiator identity in Escherichia coli. J. Bacteriol. (1993) 175:4507-4514.
16. SAMUEL CE, MURRAY CL, RABINOWITZ JC: Methionine transfer ribonucleic acid from folate-sufficient and folate-deficient Streptococcus faecalis R.J. Biol. Chem. (1972) 247:6856-6865.
17. GUILLON JM, MECHULAM Y, SCHMITTER JM, BALNQUET S, FAYAT G: Disruption of the gene for Met-tRNAMetf formyltransferase severely impairs the growth of Escherichia coli. J. Bacteriol. (1992) 174:4294-4301.
18. MAZEL D, POCHET S, MARLIERE P: Genetic characteriza tion of polypeptide deformylase, a distinctive enzyme of eubacterial translation. EMBOJ. (1994) 13:914-923.
19. NEWTON DT, CREUZENET C, MANGROO D: Formylation is not essential for initiation of protein synthesis in all eubacteria. J. Biol. Chem. (1999) 274:22143-22146.
20. MARGOLIS PS, HACKBARTH CJ, YOUNG DC et al: Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob. Agents Chemother. (2000) 44:1825-1831.
21. SOLBIATI J, CHAPMAN-SMITH A, MILLER JL, MILLER CG, CRONAN JE JR: Processing of the N-termini of nascent polypeptide chains requires deformylation prior to methionine removal. J. Mol. Biol. (1999) 290:607-614.
22. CHANG SYP, MCGARY EC, CHANG S: Methionine aminopeptidase gene of Escherichia coli is essential for cell growth.J. Bacteriol. (1989) 171:4071-4072.
23. MILLER CG, KUKRAL AM, MILLER JL, MOVVA NR: pepMis an essential gene in Salmonella typhimurium. J. Bacteriol. (1989) 171:5215-5217.
24. LI X, CHANG YH: Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopepti-dases. Proc. Natl. Acad. Sci. USA (1995) 92:12357-12361.
25. GRIFFITH EC, SU Z, TURK BE et al.: Methionine aminopeptidase (Type 2) is the common target for angiogenesis inhibitors AGM-1470 andovalicin. Chem. Biol. (1997) 4:461-471.
26. SIN N, MENG L, WANG MQW, WEN J, BORNMANN WG, CREWS CM: The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. USA (1997) 94:6099-6103.
27. TSO JY, HERMODSON MA, ZALKIN H: Glutamine phosphoribosylpyro-phosphate amidotransferase from cloned Escherichia coli purF. NH2-terminal amino acid sequence, identification of the glutamine site and trace metal analysis. J. Biol. Chem. (1982) 257:3532-3536.
28. PERSSON B, FLINTA C, VON HEIJNE G, JORNVALL H: Structure of N-terminally acetylated proteins. Eur. J. Biochem. (1985) 152:523-527.
29. ARAI K, CLARK BFC, DUFFY L et al.: Primary structure of elongation factor Tu from Escherichia coli. Proc. Natl. Acad. Sci. USA (1980) 77:1326-1330.
30. YOSHIDA T, KANEKO Y, TSUKAMOTO A, HAN K, ICHINOSE M, KIMURA S: Suppression of hepatoma growth and angiogenesis by a fumagillin derivative TNP-470: Possible involvement of nitric oxide synthase. Cancer Res. (1998) 58:3751-3756.
31. VARSHAVSKY A: The N-end rule: functions, mysteries and uses. Proc. Natl. Acad. Sci. USA(1996) 93:12142-12149.
32. MEINNEL T, BLANQUET S: Characterization of the Thermus thermophilus locaus encoding peptide deformylase and methionyl-tRNAMetf formyltransfe-rase. J. Bacteriol. (1994) 176:7387-7390.
33. MEINNEL T, BLANQUET S: Evidence that peptide deformylase and methionyl-tRNA (fMet) formyltrans-ferase are encoded within the same operon inEscheri-chia coli. J. Bacteriol. (1993) 175:7737-7740.
34. VALLEE BL, AULD DS: Zinc coordination, function and structureinzincenzymes and otherproteins.Biochemistry (1990) 29:5647-5659.
35. MEINNEL T, LAZENNEC C, BLANQUET S: Mapping the active site zinc ligands of peptide deformylase. J. Mol. Biol. (1995) 254:175-183.
36. MEINNEL T, BLANQUET S, DARDEL F: A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase. J. Mol. Biol. (1996) 262:375-386.
37. CHAN MK, GONG W, RAJAGOPALAN PTR, HAO B, TSAI CM, PEI D: Crystal structure of the Escherichia coli peptide deformylase. Biochemistry (1997) 36:13904-13909.
38. BECKER A, SCHLICHTING I, KABSCH W, SCHULTZ S, WAGNER AFV: Structure of peptide deformylase and identification the substrate binding site. J. Biol. Chem. (1998) 273:11413-11416.
39. BECKER A, SCHLICHTING I, KABSCH W, GROCHE D, SCHULTZ S, WAGNER AF: Iron center, substrate recognition and mechanism of peptide deformylase. Nature Struct. Biol. (1998) 5:1053-1058.
40. HAO B, GONG W, RAJAGOPALAN PTR, ZHOU Y, PEI D, CHAN MK: Structural basis for the design of antibiotics targeting peptide deformylase. Biochemistry (1999) 38:4712-4719.
41. DARDEL F, RAGUSA S, LAZENNEC C, BLANQUET S, MEINNEL T: Solution structure of nickel-peptide deformylase. J. Mol. Biol. (1998) 280:501-513.
42. O'CONNELL JF, PRYOR KD, GRANT SK, LEITING B: Ahigh quality nuclear magnetic resonance solution structure of peptide deformylase from Escherichia coli: applicationofanautomated assignmentstrategy using GARANT. J. Biomol. NMR (1999) 13:311-324.
43. MEINNEL T, BLANQUET S: Enzymatic properties of Escherichia coli peptide deformylase. J. Bacteriol (1995) 177:1883-1887.
44. RAJAGOPALAN PTR, DATTA A, PEI D: Purification, characterization and inhibition of peptide deformy lase from Escherichia coli. Biochemistry (1997) 36:13910-13918.
45. RAJAGOPALAN PTR, YU XC, PEI D: Peptide deformylase: a new type of mononuclear iron protein. J. Am. Chem. Soc. (1997) 119:12418-12419.
46. GROCHE D: Charackterisierung des eisenzentrum und des katalysemechanismus von peptide deformylase aus Escherichia coli. PhD Thesis, Universitat Heidelberg, Germany (1995).
47. GROCHE D, BECKER A, SCHLICHTING I, KABSCH W, SCHULTZ S, WAGNER AFV: Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site. Biochem. Biophys. Res. Comm. (1998) 246:342-346.
48. RAJAGOPALAN PTR, PEI D: Oxygen mediated inactiva-tion of peptide deformylase. J. Biol. Chem. (1998) 273:22305-22310.
49. RAGUSA S, BLANQUET S, MEINNEL T: Control of peptide deformylase activity by metal ions. J. Mol. Biol. (1998) 280:515-523.
50. RAJAGOPALAN PTR, GRIMME S, PEI D: Characterization of cobalt(II)-substituted peptide deformylase: function of the metal ion and the catalytic residue Glu-133. Biochemistry (2000) 39:779-790.
51. EIDSNESS MK, O'DELL SE, KURTZ DM JR, ROBSON RL, SCOTT RA: Expression of a synthetic gene coding for the amino acid sequence of Clostridium pasteu-rianum rubredoxin. Protein Eng. (1992), 5 (4):367-371.
52. CZAJA C, LITWILLER R, TOMLINSON AJ et al: Expression of Desulfovibriogigasdesulforedoxin in Escherichia coli. Purification and characterization of mixed metal isoforms. J. Biol. Chem. (1995) 270 (35):20273-20277.
53. MAZEL D, COIC E, BLANCHARD S, SAURIN W, MARLIERE P: A survey of polypeptide deformylase function throughout the eubacterial lineage. J. Mol. Biol. (1997) 266:939-949.
54. MEINNEL T, LAZENNEC C, VILLOING S, BLANQUET S: Structure-function relationship within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion. J. Mol. Biol. (1997) 267:749-761.
55. EVANS VJ, LIYANAGE H, RAVAGNANIA et al: Truncation of peptide deformylase reduces the growth rate and stabilizes solvent production in Clostridium beijer-inckii NCIMB 8052. Appl. Environ. Microbiol. (1998) 64 (5):1780-1785.
56. BELOUSKI E, GUI L, RUDOLPH FB, BENNETT GN: Complementation of an Ecsherichia coli polypeptide deformylase mutant with a gene from Clostridium acetobutylicum ATCC 824. Curr. Miocrobiol (1998) 36:248-249.
57. GIGLIONE C, SERERO A, PIERRE M et al: Identification of eukaryotic peptide deformylases reveals universality of N-terminal processing mechanisms. EMBOJ. (2000) 19 (21):5916-5929.
58. HUNTINGTON KM, YI T, WEI Y, PEI D: Synthesis and antibacterial activity of peptide deformylase inhibitors. Biochemistry (2000) 39:4543-4551.
59. BRACCHI-RICARD V, ZHOU Y, RAJAGOPALAN PTR, CHAKRABARTI D, PEI D: Characterization of an eukary-otic peptide deformylase from Plasmodium falciparum. (Submitted).
60. HU YJ, WEI Y, ZHOU Y, RAJAGOPALAN PTR, PEI D: Determination of substrate specificity for peptide deformylase through the screening of a combinatorial peptide library. Biochemistry (1999) 38:643-650.
61. RAGASU S, MOUCHET P, LAZENNEC C, DIVE V, MEINNEL T: Substrate recognition and selectivity of peptide deformylase. Similarities and differences with metzincins and thermolysin. J. Mol. Biol. (1999) 289:1445-1457.
62. GIGLIONE C, PIERRE M, MEINNEL T: Peptide deformy lase as a target for new generation, broad spectrum antimicrobial agents. Mol. Microbiol. (2000) 36:1197-1205.
63. BIANCHETTI R, LUCCHINI G, SARTIRANA ML: Endogenous synthesis of formylmethionine peptides in isolated mitochondria and chloroplasts. Biochem. Biophys. Res. Comm. (1971) 42:97-102.
64. FELDMAN F, MAHLER HR: Mitochondrial biogenesis: Retention of terminal formylmethionine in membrane proteins and regulation of their synthesis. J.Biol. Chem. (1974) 249:3702-3709.
65. MAHLER HR: Biogenetic autonomy of mitochondria. CRC Crit. Rev. Biochem. (1973) 1:381-460.
66. MAHLER HR, DAWIDOWICZ K, FELDMAN F: Formate as a specific label for mitochondrial translational products. J. Biol. Chem. (1972) 247:7439-7442.
67. MANNHAUPT G, BEYREUTHER K, MICHAELIS G: Cytochrom b, the var 1 protein and subunits Iand IIIof cytochrome c oxidase are synthesized without transient presequence in Saccharomyces cerevisiae. Eur. J. Biochem. (1985) 150:435-439.
68. VELOURS J, ESPARZA M, HOPPE J, SEBALD W, GUERIN B: Amino acid sequence of a new mitochondrially synthesized proteolipid of the ATP synthase of Saccharomyces cerevisiae. EMBO J. (1984) 3:207-212.
69. SEBALD W, WACHTER E: Energy conservation in biological membranes. SCHAFER G, KLINGENBERG M (Eds.), Springer, Berlin, Germany (1978):228-236.
70. WEISS H: Subunit composition and biogenesis of mitochondrial cytochrome b. Biochim. Biophys. Acta (1976) 456:291-313.
71. TUSCHEN G, SACKMAN U, NEHLS U, HAIKER H, BUSE G, WEISS H: Assembly of NADH: ubiquinone reductase (Complex I) in neurospora mitochondria, Independent pathways of nuclear-encoded and mitochondrially encoded subunits. J. Mol. Biol. (1990) 213:845-857.
72. POLZ G, KREIL G: Presence of N-formyl-and N-acetyl-methionine in the peoteins of the honey bee throax. Biochem. Biophys. Res. Comm. (1970) 39:516-521.
73. VON JAGOW G, ENGEL WD, SCHAGGER H, MACHLEIDT W, MACHLEIDT I: Onthe mechanism of proton translo-cation linkedtoelectron transferatenergy conversion site 2. In: Vectorial Reactions in Electron and Ion Transport in Mitochondria and Bacteria. Palmieri et al. (Eds.), Elsevier, Amsterdam, Holland (1981):149-161.
74. STEFFENS GJ, BUSE G: Studieson cytochromec oxidase I. Hoppe-Seyler's Z. Physiol. Chem. (1976) 357:1125-1137.
75. STEFFENS GJ, BUSE G:Studiesoncytochromecoxidase, IV. Primary structure and function of subunit II. Hoppe-Seylaer's Z. Physiol. Chem. (1979) 360:613-619.
76. FEARNLEY IM, WALKER JF: Two overlapping genes in bovine mitochondrial DNA encode membrane components of ATP synthase. EMBO J. (1986) 5:2003-2008.
77. YAGI T, HATEFI Y: Identification of the dicyclohexylcarbodiimide-binding subunit of NADH-ubiquinone oxidoreductase (complex I). J. Biol. Chem. (1988) 263:16150-16155.
78. WALKER JE, LUTTER R, DUPUIS A et al.: Identification of the subunits of F1F0-ATPase from bovine heart mitochondria. Biochemistry (1991) 30:5369-5378.
79. RABINOVICH YM, BEZBORODOVA OA: Incorporation of labeled formate into rat liver mitochondrial proteins and protein synthesis initiation. Biokhimiya (1986) 51(8):122-1328.
80. BRAUN HP, SCHMITZ UK: Purification and sequencing of cytochrome b from potato reveals methionine cleavage of a mitochondrially encoded protein. FEBS Lett. (1993) 316:128-132.
81. GAEBLER L, HERZ U, LIDDELL A et al.: The 42.5 kDa subumit of the NADH: ubiquinone oxidoreductase (complex I) in higher plants is encoded by the mitochondrial nad7 gene. Mol. Gen. Genet. (1994) 244(1):33-40.
82. HERZ U, SCHROEDER W, LIDDELL A et al.: Purification of the NADH:ubiquinone oxidoreductase (complex I) of the respiratory chain from the inner mitochondrial membrane of Solanum tuberosum. J. Biol. Chem. (1994) 269(3):2263-2269.
83. HAUSKA G, NITSCHKE W, HERRMANN RG: Amino acid identities in the three redox center-carrying polypep-tides of cytochrome bc1/b6f complexes. J. Bioenerg. Biomemb. (1988) 20:211-228.
84. SCHMIDT J, HERFUTHE, SUBRAMANIAN AR: Purification and characterization of seven chloroplast ribosomal proteins: evidence that organelle ribosomal protein genes are functional and that NH2-terminal processing occurs via multiple pathways in chloroplasts. Plant Mol. Biol. (1992) 20:459-465.
85. SHANKLIN J, DEWITT ND, FLANAGAN JM: The stroma of higher plant plastids contain ClpP and ClpC, functional homologues of Escherichia coli ClpP and ClpA: an archetypal two-component ATP-dependent proteases. Plant Cell (1995) 7:1713-1722.
86. MEINNEL T: Peptide deformylase of eukaryotic protists: a target for new antiparasitic agents? Parasitol Today (2000) 16:165-168.
87. APFEL C, BANNER DW, BUR D et al.: Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents. J. Med. Chem. (2000) 43:2324-2331.
88. LAZENNEC C, MEINNEL T: Formate dehydrogenase-coupled spectrophotometric assay of peptide deformylase. Anal. Biochem. (1997) 244:180-182.
89. WEI Y, PEI D: Continuous spectrophotometric assay of peptide deformylase. Anal Biochem. (1997) 250:29-34.
90. GUO X-C, RAJAGOPALAN PTR, PEI D: A direct spectrophotometric assay for peptide deformylase. Anal Biochem. (1999) 273:298-304.
91. HU Y-J, RAJAGOPALAN PTR, PEI D: H-Phosphonate derivatives as novel peptide deformylase inhibitors. Bioorg. Med. Chem. Lett. (1998) 8:2479-2482.
92. WEI Y: Peptide deformylase: characterization and antibacterial drug design. PhD Thesis, The Ohio State University, Columbus, Ohio, USA (1999).
93. DURAND DJ, GREEN B, O'CONNELL JF, GRANT SK: Peptide aldehyde inhibitors of bacterial peptide deformylases. Arch. Biochem. Biophys. (1999) 367:297-302.
94. MEINNEL T, PATINY L, RAGASU S, BLANQUET S: Design and synthesis of substrate analogue inhibitors of peptide deformylase. Biochemistry (1999) 38:4287-4295.
95. WEI Y, YI T, HUNTINGTON KM, CHAUDHURY C, PEI D: Identification of potent peptide deformylase inhibitors from a rationally designed combinatorial library. J. Comb. Chem. (2000) 2 (6):650-657.
96. CHEN DZ, PATEL DV, HACKBARTH CJ et al: Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry (2000) 39:1256-1262.
97. GREEN BG, TONEYJH, KOZARICHJW, GRANT SK: Inhibi tion of bacterial peptide deformylase by biaryl acid analogs. Arch. Biochem. Biophys. (2000) 375:355-358.
98. JAYASEKERA MMK, KENDALL A, SHAMMAS R et al.: Novel non-peptidic inhibitors of peptide deformylase. Arch. Biochem. Biophys. (2000) 381 (2): 313-316.
99. WEI Y, PEI D: Activation of antibacterial prodrugs by peptide deformylase. Bioorg. Med. Chem. Lett. (2000) 10:1073-1076.
100. SANTI DV, MCHENRY CS, RAINES RT et al: Kinetics and thermodynamics of the interaction of 5-fluoro-'2-deoxyuridylate with thymidylate synthase. Biochemistry (1987) 26 (26):8606-8613.
101. MEINNEL T, GUILLON J-M, MECHULAM Y, BLANQUET S: The Escherichia coli fmt gene, encoding methionyl-tRNAfMet formyltransferase, escapes metabolic control. J. Bacteriol. (1993) 175 (4):993-1000.
102. LIPINSKI CA, LOMBARDO F, DOMINY BW et al: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development stages. Adv. Drug Delivery Rev. (1997) 23:3-25.
103. MARASCO WA, PHAN SH, KRUTZSCH H et al: Purification and Identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol Chem. (1984) 259:5430-5439.
104. BROOM MF, MELLOR DM, CHADWICK VS: Purification and amino acid sequencing of naturally occurring N-formyl-methionyl oligopeptides from Escherichia coli. Experimentia (1989) 45:1097-1099.
105. ADEYEMIEO, CHADWICK VS, HODGSON HJF: The effect of some anti-inflammatory agents on elastase release from neutrophils in vitro. J. Phar. Pharmacol. (1990) 42:487-490.
106. CHESTER JF, ROSS JS, MALT RA, WEITZMAN SA: Acute colitis produced by chemotactic peptides in rats and mice. Am. J. Path. (1985) 121:284-290.
107. NAST CC, LEDUC LE: Chemotactic peptides. Mechanisms,functions and possible role in inflammatory bowel disease. Dig. Dis. Sci. (1988) 33:50S-57S.
108. SHERRIFF RM, BROOM MF, CHADWICK VS: Isolation and purification of N-formylmethionine aminopeptidase from rat intestine. Biochem. Biophys. Acta (1992) 1119:275-280.
109. BROOM MF, SHERRIFF RM, TATE WP, COLLINGS J, CHADWICK, VS: Partial purification and characterization of a formylmethionine deformylase from rat small intestine. Biochem. J. (1989) 257:51-56.